ArticleBrain communications2025
Frontotemporal dementia characterization using neurite orientation dispersion and density imaging.
Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Bibliometric analysis of neurite orientation dispersion and density imaging: research patterns, evolution, and frontier.Frontiers in neuroscience · 2026Pooled it
- Mapping neurodegeneration with diffusion MRI: biomarkers, mechanisms, and clinical translation.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microstructural alterations in brain tissue play a crucial role in the pathophysiology of frontotemporal dementia (FTD). This study assessed brain white matter (WM) and grey-matter (GM) microstructure in FTD variants using neurite orientation dispersion and density imaging (NODDI) diffusion MRI model and developed an exploratory machine-learning algorithm to classify FTD subtypes according to diffusion MRI metrics. Brain MRI including multi-shell diffusion sequences and neuropsychological assessment were obtained in controls and participants with FTD: 35 behavioural variant of FTD (bvFTD), 20 semantic-variant primary progressive aphasia (svPPA), 14 nonfluent-variant primary progressive aphasia (nfvPPA), 9 semantic-bvFTD (sbvFTD). Fractional anisotropy (FA), mean diffusivity (MD), intracellular-volume fraction (ICVF), and orientation-dispersion index (ODI) were analysed using tract-based and GM-based spatial statistic at the voxel-wise level, with nonparametric and permutation-based methods. Support vector machine (SVM) models were trained on different combinations of diffusion MRI and neuropsychological features to classify FTD subtypes. FA and MD showed widespread WM alterations in all variants. ICVF showed reductions in both WM and GM (bilateral frontotemporal for bvFTD, left temporal-frontal for svPPA and nfvPPA and right temporal for sbvFTD). GM ODI reduction exhibited a similar but more diffuse pattern compared with ICVF. WM ODI alterations were also observed, with specific WM alterations in the corpus callosum and long-range WM tracts when comparing FTD syndromes. SVM algorithm, trained on mean FA, ICVF and ODI values from different brain lobes and neuropsychological scores, achieved 98.6% accuracy in classifying different clinical syndromes, outperforming standard diffusion tensor (DT) imaging-based models. NODDI capture subtle microstructural alterations in brain GM and WM, demonstrating advantages over standard DT imaging in capturing disease-relevant alterations. By integrating NODDI with cognitive data, machine-learning models can learn complex patterns and relationships facilitating the differentiation of FTD subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.